Orgovyx

relugolix · Accord Healthcare S.L.U.
AUTHORISED IN THE EU

What Orgovyx is used for

Orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Approved use, as published by the European Medicines Agency.

Key facts

Brand
Orgovyx
Active substance
relugolix
Disease area
Prostatic Neoplasms
Medicine group
Endocrine therapy
ATC code
L02BX
Marketing authorisation holder
Accord Healthcare S.L.U.
Authorised in the EU since
2022

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Orgovyx used for?

Orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

What is the active substance in Orgovyx?

Orgovyx contains relugolix.

Who makes Orgovyx?

The EU marketing authorisation holder is Accord Healthcare S.L.U..

Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, EU

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.